1. Feng, Ziyang, Chen, Yu, Cai, Changjing, Zeng, Shan, Han, Ying. 2022. Pan-Cancer and Single-Cell Analysis Reveals CENPL as a Cancer Prognosis and Immune Infiltration-Related Biomarker. In Frontiers in immunology, 13, 916594. doi:10.3389/fimmu.2022.916594. https://pubmed.ncbi.nlm.nih.gov/35844598/
2. Cui, Zhongyuan, Du, Ling, Wang, Jielong, Chen, Gang, Wu, Zhixian. 2022. Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients. In BMC cancer, 22, 1354. doi:10.1186/s12885-022-10450-5. https://pubmed.ncbi.nlm.nih.gov/36572856/
3. Gui, Zhengwei, Tian, Yao, Liu, Shiyang, Liu, Chenguang, Zhang, Lin. 2023. Highly expressed CENPL is correlated with breast cancer cell proliferation and immune infiltration. In Frontiers in oncology, 13, 1046774. doi:10.3389/fonc.2023.1046774. https://pubmed.ncbi.nlm.nih.gov/36816951/
4. He, Kun, Xie, Mengyi, Hong, Weifeng, You, Chuan, Li, Jingdong. 2023. CENPL accelerates cell proliferation, cell cycle, apoptosis, and glycolysis via the MEK1/2-ERK1/2 pathway in hepatocellular carcinoma. In The international journal of biochemistry & cell biology, 166, 106481. doi:10.1016/j.biocel.2023.106481. https://pubmed.ncbi.nlm.nih.gov/37914022/
5. Cui, Zhongyuan, Xiao, Lijia, Chen, Fengsui, Li, Dongliang, Wu, Zhixian. 2021. High mRNA Expression of CENPL and Its Significance in Prognosis of Hepatocellular Carcinoma Patients. In Disease markers, 2021, 9971799. doi:10.1155/2021/9971799. https://pubmed.ncbi.nlm.nih.gov/34457090/
智鼠故事 
